These changes suggest that miRNAs may have a functional role in the ischemic processes and thus make for attractive therapeutic targets given the upregulation of angiogenic VEGFA in the TAT and the potential involvement of miRNA regulation in ischemic cardiomyopathy. The gene discussed is VEGFA; the disease is ischemic cardiomyopathy.